MCID: CHC001
MIFTS: 53

Chickenpox

Categories: Immune diseases, Infectious diseases, Reproductive diseases, Skin diseases

Aliases & Classifications for Chickenpox

MalaCards integrated aliases for Chickenpox:

Name: Chickenpox 12 75 43 3 44 15 63 17 72
Varicella 12 55 15

Classifications:



External Ids:

Disease Ontology 12 DOID:8659
ICD9CM 35 052
MeSH 44 D002644
NCIt 50 C97132
SNOMED-CT 68 38907003
ICD10 33 B01 B01.8 B01.9
UMLS 72 C0008049

Summaries for Chickenpox

MedlinePlus : 43 Chickenpox is an infection caused by the varicella-zoster virus. Most cases are in children under age 15, but older children and adults can get it. It spreads very easily from one person to another. The classic symptom of chickenpox is an uncomfortable, itchy rash. The rash turns into fluid-filled blisters and eventually into scabs. It usually shows up on the face, chest, and back and then spreads to the rest of the body. Other symptoms include Fever Headache Tiredness Loss of appetite Chickenpox is usually mild and lasts 5 to 10 days. Calamine lotions and oatmeal baths can help with itching. Acetaminophen can treat the fever. Do not use aspirin for chickenpox; that combination can cause Reye syndrome. Chickenpox can sometimes cause serious problems. Adults, babies, teenagers, pregnant women, and those with weak immune systems tend to get sicker from it. They may need to take antiviral medicines. Once you catch chickenpox, the virus usually stays in your body. You probably will not get chickenpox again, but the virus can cause shingles in adults. A chickenpox vaccine can help prevent most cases of chickenpox, or make it less severe if you do get it. Centers for Disease Control and Prevention

MalaCards based summary : Chickenpox, also known as varicella, is related to fasciitis and spindle cell sarcoma, and has symptoms including fever, myalgia and anorexia. An important gene associated with Chickenpox is GYPC (Glycophorin C (Gerbich Blood Group)), and among its related pathways/superpathways are T cell receptor signaling pathway and Cell adhesion molecules (CAMs). The drugs Prednisolone phosphate and Methylprednisolone hemisuccinate have been mentioned in the context of this disorder. Affiliated tissues include skin, t cells and testes.

Disease Ontology : 12 A viral infectious disease that results in infection located in skin, has material basis in Human herpesvirus 3, which is transmitted by direct contact with secretions from the rash, or transmitted by droplet spread of respiratory secretions. The infection has symptom anorexia, has symptom myalgia, has symptom nausea, has symptom fever, has symptom headache, has symptom sore throat, and has symptom blisters.

CDC : 3 Chickenpox is a highly contagious disease caused by the varicella-zoster virus (VZV). It can cause an itchy, blister-like rash. The rash first appears on the chest, back, and face, and then spreads over the entire body, causing between 250 and 500 itchy blisters. Chickenpox can be serious, especially in babies, adolescents, adults, pregnant women, and people with a weakened immune system. The best way to prevent chickenpox is to get the chickenpox vaccine.

PubMed Health : 63 About chickenpox: Chickenpox is a highly contagious viral infection which mainly affects children. Typical symptoms include a very itchy skin rash with red blisters and a mild fever. Because most children are now vaccinated, chickenpox (also referred to as varicella) is much less common than it was in the past. If someone comes down with chickenpox, they are contagious after just one or two days, which is before they have a visible rash. But taking precautions and improving hygiene can help to avoid infecting others. Although chickenpox is unpleasant, it rarely has any serious consequences in children who are otherwise healthy. But it may become more severe in newborns and adults, as well as people who have a weakened immune system.

Wikipedia : 75 Chickenpox, also known as varicella, is a highly contagious disease caused by the initial infection with... more...

Related Diseases for Chickenpox

Diseases related to Chickenpox via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 938)
# Related Disease Score Top Affiliating Genes
1 fasciitis 31.3 MUC1 ACTC1
2 spindle cell sarcoma 30.2 MUC1 ACTC1
3 mammary paget's disease 30.1 PGR MUC1
4 cryptogenic organizing pneumonia 30.0 MUC1 CD8A
5 pneumothorax 29.8 PGR MUC1
6 varicella, severe recurrent 12.2
7 herpes zoster 12.2
8 congenital varicella syndrome 12.1
9 geniculate herpes zoster 11.8
10 postherpetic neuralgia 11.7
11 myoclonus and ataxia 11.6
12 cytomegalic inclusion disease 11.5
13 cytomegalovirus infection 11.3
14 immunodeficiency 50 11.2
15 immunodeficiency 24 11.2
16 salivary gland disease 11.2
17 neurological consequences of cytomegalovirus infection 11.2
18 infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations 11.1
19 immunodeficiency 62 11.1
20 idiopathic cd4-positive t-lymphocytopenia 11.1
21 adult-onset immunodeficiency with anti-interferon-gamma autoantibodies 11.1
22 torch syndrome 11.1
23 measles 10.7
24 exanthem 10.7
25 cutaneous leiomyosarcoma 10.7 MUC1 ACTC1
26 calcifying aponeurotic fibroma 10.7 PGR ACTC1
27 syringocystadenoma papilliferum 10.7 MUC1 ACTC1
28 parachordoma 10.6 MUC1 ACTC1
29 myxoid leiomyosarcoma 10.6 PGR ACTC1
30 ossifying fibromyxoid tumor 10.6 MUC1 ACTC1
31 bizarre leiomyoma 10.6 PGR ACTC1
32 breast mucoepidermoid carcinoma 10.6 PGR MUC1
33 breast scirrhous carcinoma 10.6 PGR MUC1
34 benign metastasizing leiomyoma 10.6 PGR ACTC1
35 endosalpingiosis 10.6 PGR MUC1
36 adenofibroma 10.6 MUC1 ACTC1
37 spiradenoma 10.6 MUC1 ACTC1
38 cystadenoma 10.6 PGR MUC1
39 ischemic fasciitis 10.6 MUC1 ACTC1
40 apocrine adenocarcinoma 10.6 PGR MUC1
41 endometrial mucinous adenocarcinoma 10.6 PGR MUC1
42 glycogen-rich clear cell breast carcinoma 10.6 PGR ACTC1
43 clear cell meningioma 10.6 PGR MUC1
44 pneumonia 10.6
45 sertoli cell tumor 10.6 PGR MUC1
46 dendritic cell tumor 10.6 MUC1 ACTC1
47 sclerosing hemangioma 10.6 PGR MUC1
48 mumps 10.6
49 sertoli-leydig cell tumor 10.6 PGR MUC1
50 dermoid cyst 10.6 PGR MUC1

Graphical network of the top 20 diseases related to Chickenpox:



Diseases related to Chickenpox

Symptoms & Phenotypes for Chickenpox

Symptoms:

12
  • fever
  • myalgia
  • anorexia
  • headache
  • nausea
  • sore throat
  • blisters

UMLS symptoms related to Chickenpox:


fever, pruritus, exanthema

Drugs & Therapeutics for Chickenpox

PubMed Health treatment related to Chickenpox: 63

The treatment usually focuses on relieving the symptoms of chickenpox. In more severe cases, or if there is a greater risk of complications, antiviral drugs can be used to fight off the virus. Lotions, gels and powders are often applied in order to relieve itching and dry out the blisters. Most of them contain tanins, zinc, menthol or polidocanol. Sometimes oral medication like antihistamines is also recommended to stop the itching. But there is no good-quality scientific research on how effective they are. Symptoms like fever or aching muscles can be relieved using medicine that contains acetaminophen (paracetamol). The painkiller ibuprofen is not suitable for children with chickenpox. Children and teenagers should only take acetylsalicylic acid (ASA, the drug in medicines like Aspirin) if it has been prescribed by a doctor, and only as a last resort. This is because it can cause a rare but dangerous side effect called Reye’s syndrome in children and teenagers.

Drugs for Chickenpox (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 179)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
2
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5
3
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
4
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
5
Ethanol Approved Phase 4 64-17-5 702
6
Budesonide Approved Phase 4 51333-22-3 63006 5281004
7
Interferon beta-1a Approved, Investigational Phase 4 145258-61-3 6438354
8
Interferon beta-1b Approved Phase 4 145155-23-3
9
Fluticasone Approved, Experimental Phase 4 90566-53-3 62924
10
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
11
Racepinephrine Approved Phase 4 329-65-7 838
12
Mercaptopurine Approved Phase 4 50-44-2 667490
13
Certolizumab pegol Approved Phase 4 428863-50-7
14
Adalimumab Approved Phase 4 331731-18-1 16219006
15
Azathioprine Approved Phase 4 446-86-6 2265
16
Tofacitinib Approved, Investigational Phase 4 477600-75-2
17
Methotrexate Approved Phase 4 1959-05-2, 59-05-2 126941
18
Prednisone Approved, Vet_approved Phase 4 53-03-2 5865
19
Prednisolone hemisuccinate Experimental Phase 4 2920-86-7
20 Hormone Antagonists Phase 4
21 glucocorticoids Phase 4
22 Hormones Phase 4
23 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4
24 Methylprednisolone Acetate Phase 4
25 Antineoplastic Agents, Hormonal Phase 4
26 Prednisolone acetate Phase 4
27 Vaccines Phase 4
28 Anti-Inflammatory Agents Phase 4
29 Peripheral Nervous System Agents Phase 4
30 Respiratory System Agents Phase 4
31 Anti-Asthmatic Agents Phase 4
32 Autonomic Agents Phase 4
33 Bronchodilator Agents Phase 4
34 Anti-Infective Agents, Local Phase 4
35 Dermatologic Agents Phase 4
36 Fingolimod Hydrochloride Phase 4
37 (T,G)-A-L Phase 4
38 Interferon-beta Phase 4
39
Glatiramer Acetate Phase 4 147245-92-9 3081884
40 interferons Phase 4
41 Anti-Allergic Agents Phase 4
42 Epinephryl borate Phase 4
43 Antiviral Agents Phase 4
44 valacyclovir Phase 4
45 Mesalamine Phase 4 89-57-6
46 Heptavalent Pneumococcal Conjugate Vaccine Phase 4
47 Protein Kinase Inhibitors Phase 4
48 Janus Kinase Inhibitors Phase 4
49 polysaccharide-K Phase 4
50
Methylene blue Approved, Investigational Phase 3 61-73-4

Interventional clinical trials:

(show top 50) (show all 253)
# Name Status NCT ID Phase Drugs
1 A Study of Immune Persistence After Inoculated With One-dose Freeze-dried Live Attenuated Varicella Vaccine in Children Aged 1-6 Years Unknown status NCT01982409 Phase 4
2 Study on Effectiveness of 2-dose Live Attenuated Varicella Vaccine Unknown status NCT02146469 Phase 4
3 Phase 4 Study of the Varicella Vaccine After the 2nd Dose Vaccination Unknown status NCT01830283 Phase 4
4 Phase 4 Study of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination Unknown status NCT01866566 Phase 4
5 Safety and Immunogenicity of Live Attenuated Herpes Zoster Vaccine in Patients Undergoing Living Donor Kidney Transplantations Unknown status NCT00940940 Phase 4
6 A Pilot Study to Characterize the Immune Response Induced by a Commercial Varicella Zoster Virus Vaccine in Healthy Adult Females in Nairobi, Kenya. Unknown status NCT02514018 Phase 4
7 Immunodeficiency in Cartilage-hair Hypoplasia: Correlation With Pulmonary Disease, Infections and Malignancy Unknown status NCT02383797 Phase 4
8 Efficacy of Systemic Glucocorticoid in the Treatment of Wheezing in Children Unknown status NCT00494624 Phase 4 prednisolone
9 A Study to Evaluate the Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine Completed NCT01817270 Phase 4
10 Rates of Seroconversion Following Varicella Vaccination of Asthmatic Children Between the Ages of One and Eight Years Treated With Pulmicort Respules® Versus Non-Steroidal Conventional Asthma Therapy Completed NCT00641446 Phase 4 budesonide;varicella zoster virus
11 A Study to Evaluate the Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella Vaccine Completed NCT02173899 Phase 4
12 Blinded, Randomised Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Live Attenuated Measles-mumps-rubella-varicella Candidate Vaccine When Given to Healthy Children in Their Second Year of Life Completed NCT00126997 Phase 4
13 A Study to Evaluate the Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine Completed NCT01815073 Phase 4
14 Safety of a Second Dose of Biken's Varicella Vaccine Administered at 4 to 6 Years of Age in Healthy Children in Argentina Completed NCT00830648 Phase 4
15 A Double-blind, Randomised, Controlled, Multi-centre Safety Study of a Refrigerator-stable Formulation of VARIVAX® in Healthy 12 to 15 Month-old Infants. Completed NCT00432731 Phase 4
16 Evaluation of Safety and Immunogenicity Receiving Live Attenuated Vaccine Against Varicella Without Gelatin Completed NCT01684072 Phase 4
17 An Open, Multicenter Study of the Safety and Tolerability of VAQTA(TM) and ProQuad(TM) in Healthy Children 12 to 23 Months of Age Completed NCT00326183 Phase 4
18 Live Attenuated Varicella Vaccine: A New Effective Adjuvant Weapon in the Battlefield Against Severe Resistant Psoriasis, a Randomized Controlled Trial Completed NCT01356004 Phase 4 live attenuated chicken pox vaccine;saline, efficacy
19 The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children Completed NCT01138215 Phase 4
20 T Cell Responses to Varicella Zoster Virus After Vaccination and Viral Escape Completed NCT01911065 Phase 4
21 An Open, Randomized, Multicenter Study of the Safety, Tolerability, & Immunogenicity of VAQTA™ Given Concomitantly With PROQUAD™ and PREVNAR™ in Healthy Children 12 Months of Age Completed NCT00312858 Phase 4
22 An Open-label, Single-arm, Phase IV Study Assessing the Immunogenicity and Safety of ZOSTAVAX® at Minimum Release Specification Approaching Expiry Potency in Subjects ≥50 Years Old. Completed NCT00681031 Phase 4
23 Palatability Testing of a New Paediatric Formulation of Valacyclovir for the Prophylaxis and Treatment of VZV and HSV Infections in Children Completed NCT01682109 Phase 4 Valacyclovir
24 Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza the in São Paulo, 2009 Completed NCT01693380 Phase 4
25 Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavax™ Completed NCT02958345 Phase 4
26 Immunogenicity and Safety of a Tetanus-diphtheria Vaccine and a 13-valent Pneumococcal Conjugate Vaccine After Concomitant Vaccination in ≥50-year-old Adults Completed NCT03552445 Phase 4
27 The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection Adaptive Immune Responses and Repertoire in Influenza Vaccination and Infection Completed NCT03453801 Phase 4
28 A 12-month, Prospective, Randomized, Active-controlled, Open-label Study to Evaluate the Patient Retention of Fingolimod vs. Approved First-line Disease Modifying Therapies in Adults With Relapsing Remitting Multiple Sclerosis (PREFERMS) Completed NCT01623596 Phase 4 Fingolimod;Disease Modifying therapy
29 Multicenter Randomised Controlled Trial of Episodic Fluticasone Versus Placebo in Viral-induced Asthma in Children Completed NCT00238927 Phase 4 inhaled fluticasone 750 mcg/day twice daily until 2 days without symptoms (maximum 15 consecutive days)
30 Double-Blind Placebo-Controlled Clinical Effectiveness Trial of the 23-Valent Pneumococcal Vaccine Among Military Trainees At Increased Risk of Respiratory Disease Completed NCT02079701 Phase 4
31 Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A Vaccine in HIV-exposed and HIV-unexposed South African Children Recruiting NCT03330171 Phase 4
32 Occupational Exposure to Human Papilloma Virus (HPV) and Prophylactic Vaccination (Version IV Dated 24Oct2017) Recruiting NCT03350698 Phase 4
33 Immune Response to Shingles Vaccination Recruiting NCT02624375 Phase 4 Zoster Vaccine Live
34 Safety and Immunogenicity of Non-live, Recombinant Subunit Herpes Zoster Vaccine Before and After Lung Transplantation Recruiting NCT03493776 Phase 4
35 Safety and Tolerability of Herpes Zoster Vaccine in Patients With Rheumatoid Arthritis Immunized Prior to Biologics and Tofacitinib Therapy Initiation Recruiting NCT03016884 Phase 4
36 The Immunogenicity and Safety of Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib Recruiting NCT03591770 Phase 4
37 Long-term Suppressive Valacyclovir Treatment for Herpes Zoster Ophthalmicus Recruiting NCT03134196 Phase 4 Masked Placebo;Masked Oral Valacyclovir
38 Immunogenicity and Safety of a Herpes Zoster Vaccine (Zostavax) in Patients With Systemic Lupus Erythematosus: a Randomized Controlled Trial Active, not recruiting NCT02477150 Phase 4
39 Vaccinating Children After Chemotherapy for Acute Lymphoblastic Leukemia: A Canadian Immunization Research Network Study Active, not recruiting NCT02447718 Phase 4
40 Persistence of Varicella Immunity in Hospital Employees Receiving Varicella Vaccine Not yet recruiting NCT02026089 Phase 4
41 The Immunogenicity and Efficacy of Subunit Vaccine Against Herpes Zoster in RA Treated With JAK-inhibitors (VACCIMIL-ZOSTER) Not yet recruiting NCT03886038 Phase 4
42 Safety and Immunogenicity of Recombinant Glycoprotein E Herpes Zoster Subunit (HZ/su) Vaccine in Renal Transplant Recipients Not yet recruiting NCT03993717 Phase 4
43 A Double Blind Placebo-controlled Randomized Study of Varicella Zoster Vaccine in Patients With Moderate-to-severe Plaque Psoriasis Who Are Candidates for Biologic Therapy Terminated NCT02408159 Phase 4 Varicella Zoster Vaccine;Placebo
44 Induction and Maintenance of Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients: a Retrospective and Prospective Nationwide Study in Switzerland Unknown status NCT00492739 Phase 2, Phase 3
45 Serological Evaluation of Chickenpox (Varicella) and Hepatitis A Vaccines Using Disposable Needle-Free Syringe Jet Injector (DSJI) Delivery Unknown status NCT00926419 Phase 2, Phase 3
46 Safety and Immunogenicity of Live Attenuated Oka/Merck Varicella Vaccine in Children Listed to Undergo Solid Organ Transplantation Unknown status NCT00213304 Phase 3
47 A Comparative Study of Tzanck Smear With Methylene Blue Versus Giemsa Stain to Diagnose Herpes Simplex, Herpes Zoster and Varicella Zoster Skin Infections Unknown status NCT03178747 Phase 3
48 Clinical Evaluation of Valaciclovir Hydrochloride: 256U87 in Patients With Chickenpox - Open Uncontrolled Study. Completed NCT00169416 Phase 3 valaciclovir HCl granules
49 Pharmacokinetics and Safety of Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection Completed NCT00098046 Phase 3 famciclovir
50 Blinded, Randomised, Controlled Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline Biologicals' Combined Measles-mumps-rubella-varicella Candidate Vaccine Given to Healthy Children in Their Second Year of Life Completed NCT00127023 Phase 3

Search NIH Clinical Center for Chickenpox

Inferred drug relations via UMLS 72 / NDF-RT 51 :


Acyclovir
Acyclovir
Acyclovir Sodium
Measles virus strain enders' attenuated edmonston live antigen
Mumps virus strain b level jeryl lynn live antigen
Rubella virus vaccine
Valaciclovir
Varicella Zoster Vaccine (Live/Attenuated)

Cochrane evidence based reviews: chickenpox

Genetic Tests for Chickenpox

Anatomical Context for Chickenpox

MalaCards organs/tissues related to Chickenpox:

41
Skin, T Cells, Testes, Bone, Bone Marrow, Liver, Brain

The Foundational Model of Anatomy Ontology organs/tissues related to Chickenpox:

19
Skin

Publications for Chickenpox

Articles related to Chickenpox:

(show top 50) (show all 14905)
# Title Authors PMID Year
1
Burden of varicella in Latin America and the Caribbean: findings from a systematic literature review. 38 17
31068173 2019
2
Immunogenicity, Safety, and Tolerability of Live Attenuated VaricellaZoster Virus Vaccine (ZOSTAVAX™) in Healthy Adults in India. 38 17
31325263 2018
3
Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation: A Randomized Clinical Trial. 17
31287523 2019
4
[Adenosine deaminase deficiency associated severe combined immunodeficiency with disseminated varicella infection after vaccination: a case report]. 9 38
19099832 2008
5
[Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus]. 9 38
12604384 2003
6
New variant of varicella-zoster virus. 9 38
12498673 2002
7
Expression of the simian varicella virus glycoprotein E. 9 38
11551643 2001
8
Emergence of resistance to acyclovir and penciclovir in varicella-zoster virus and genetic analysis of acyclovir-resistant variants. 9 38
10027650 1999
9
Identification of immunodominant regions and linear B cell epitopes of the gE envelope protein of varicella-zoster virus. 9 38
8553555 1995
10
Analysis of mutations in the thymidine kinase gene of varicella zoster virus associated with resistance to 5-iodo-2'-deoxyuridine and 5-bromo-2'-deoxyuridine. 9 38
7486953 1995
11
Inhibition of fluorouracil catabolism in cancer patients by the antiviral agent (E)-5-(2-bromovinyl)-2'-deoxyuridine. 9 38
8045919 1994
12
Susceptibility of Oka varicella vaccine strain to antiviral drugs. 9 38
8310756 1993
13
Genetic variants in 17q12-21 locus and childhood asthma in Brazil: Interaction with Varicella zoster virus seropositivity. 38
31357023 2019
14
Ramsay Hunt syndrome: a rare complication of herpes zoster infection in a lung cancer patient. 38
30189789 2019
15
Progeny Varicella-Zoster Virus Capsids Exit the Nucleus but Never Undergo Secondary Envelopment during Autophagic Flux Inhibition by Bafilomycin A1. 38
31217243 2019
16
Age at cytomegalovirus, Epstein Barr virus and varicella zoster virus infection and risk of atopy: The Born in Bradford cohort, UK. 38
31188509 2019
17
Virus detection in the cerebrospinal fluid of hematopoietic stem cell transplant recipients is associated with poor patient outcomes: a CIBMTR contemporary longitudinal study. 38
30696997 2019
18
Infectious causes of peripheral facial nerve palsy in children-a retrospective cohort study with long-term follow-up. 38
31372902 2019
19
Pathogen-Specific T Cells Beyond CMV, EBV and Adenovirus. 38
31228095 2019
20
Quantification of a cell-mediated immune response against varicella zoster virus by assessing responder CD4high memory cell proliferation in activated whole blood cultures. 38
31358406 2019
21
Avoiding a lumbar puncture may be a rash decision: a case report of varicella-zoster virus-associated radiculopathy in advanced HIV infection. 38
31403892 2019
22
Prudence Using Serology to Determine Vaccine-Induced Immunity to Measles and Varicella in Patients With Inflammatory Bowel Disease. 38
31165856 2019
23
Otherwise Healthy 15-Month-Old With Rapid-Onset Soft Tissue Swelling. 38
31373950 2019
24
Varicella zoster virus vaccine in patients with haematological malignancies. 38
31399379 2019
25
Measles, mumps, rubella (vaccine) and varicella vaccines in pediatric liver transplant: An initial analysis of post-transplant immunity. 38
31219224 2019
26
Field Test and Validation of the Multiplier Measles, Mumps, Rubella, and Varicella-Zoster Multiplexed Assay System in the Democratic Republic of the Congo by Using Dried Blood Spots. 38
31413172 2019
27
Calibration and Evaluation of Quantitative Antibody Titers for Varicella-Zoster Virus by Use of the BioPlex 2200. 38
31167847 2019
28
Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial. 38
31399378 2019
29
Estradiol Acts in Lateral Thalamic Region to Attenuate Varicella Zoster Virus Associated Affective Pain. 38
31271831 2019
30
Do varicella vaccination programs change the epidemiology of herpes zoster? A comprehensive review, with focus on the United States. 38
31318605 2019
31
Reply letter: trends in varicella and herpes zoster epidemiology before and after the implementation of universal one-dose varicella vaccination over one decade in South Korea, 2003-2015. 38
31311411 2019
32
[Therapy of herpes zoster and postherpetic neuralgia]. 38
31270550 2019
33
The changing epidemiology of herpes zoster over a decade in South Korea, 2006-2015. 38
31377077 2019
34
Herpes zoster vaccination efficacy in the long-term care facility population: a qualitative systematic review. 38
30913912 2019
35
Epidemiology of viral infections among children undergoing hematopoietic stem cell transplant: Α prospective single-center study. 38
30993823 2019
36
Concomitant dengue fever in Varicella zoster infection - A rare presentation. 38
31424049 2019
37
Prevention of Opportunistic Infections in Women With HIV Infection. 38
31433312 2019
38
The clinical and economic burden of varicella in the Middle East: a systematic literature review. 38
31373864 2019
39
Gadolinium enhancement in perforating arteries in a patient with varicella zoster virus vasculopathy: A case report. 38
31276861 2019
40
Varicella-zoster virus vasculopathy in a multiple sclerosis patient on fingolimod. 38
31276860 2019
41
Development of Acute Retinal Necrosis in a Patient with Ocular Sarcoidosis: A Case Report. 38
31414927 2019
42
Chronic myelitis associated with zoster sine herpete: A case report. 38
31393366 2019
43
Varicella Zoster Virus Encephalitis Mimicking Nivolumab-Induced Autoimmune Neuropathy in a Patient with Lung Cancer. 38
31345336 2019
44
Long-segment transverse myelitis in an immunocompetent patient due to varicella zoster virus reactivation. 38
31376078 2019
45
Ultrasound-guided peri-brachial plexus polydeoxyribonucleotide injection for a patient with postherpetic brachial plexopathy: A case report. 38
31374058 2019
46
Adjuvant treatment of severe varicella pneumonia with intravenous varicella zoster virus-specific immunoglobulins. 38
31132473 2019
47
Varicella Virus Vaccine Live: A 22-Year Review of Postmarketing Safety Data. 38
31392326 2019
48
Acute ataxia in paediatric emergency departments: a multicentre Italian study. 38
30948362 2019
49
Neurologic Acyclovir Toxicity in the Absence of Kidney Injury. 38
31171414 2019
50
Safety and Seropositivity after Live Attenuated Vaccine in Adult Patients Receiving Hematopoietic Stem Cell Transplantation. 38
30959161 2019

Variations for Chickenpox

Expression for Chickenpox

Search GEO for disease gene expression data for Chickenpox.

Pathways for Chickenpox

GO Terms for Chickenpox

Cellular components related to Chickenpox according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 integral component of plasma membrane GO:0005887 9.43 MUC1 GYPC CD8A CD40LG CD4 AMHR2
2 T cell receptor complex GO:0042101 9.16 CD8A CD4
3 external side of plasma membrane GO:0009897 8.92 CD8A CD40LG CD4 ADA

Biological processes related to Chickenpox according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 lung alveolus development GO:0048286 9.26 PGR ADA
2 positive regulation of T cell activation GO:0050870 9.16 CD4 ADA
3 positive regulation of calcium-mediated signaling GO:0050850 8.96 CD4 ADA
4 T cell activation GO:0042110 8.8 CD8A CD4 ADA

Molecular functions related to Chickenpox according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 coreceptor activity GO:0015026 8.62 CD8A CD4

Sources for Chickenpox

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....